These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 2986093)

  • 41. Beta-adrenergic receptors, glucagon receptors, and their relationship to adenylate cyclase in rat liver during aging.
    Dax EM; Partilla JS; Piñeyro MA; Gregerman RI
    Endocrinology; 1987 Apr; 120(4):1534-41. PubMed ID: 3030705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of beta-adrenergic sensitive adenylate cyclase in rat thoracic duct.
    Amenta F; De Rossi M; Fruschelli C; Gerli R
    J Auton Nerv Syst; 1988 Apr; 22(3):189-92. PubMed ID: 2843587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of chronic propranolol treatment on hepatic adenylate cyclase system in the rat.
    Shima S; Okeyama N; Oikawa S; Akamatsu N
    J Toxicol Sci; 1987 Aug; 12(3):309-19. PubMed ID: 2891859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of vanadate on cardiac contraction and adenylate cyclase.
    Grupp G; Grupp I; Johnson CL; Wallick ET; Schwartz A
    Biochem Biophys Res Commun; 1979 May; 88(2):440-7. PubMed ID: 223558
    [No Abstract]   [Full Text] [Related]  

  • 46. [Modifying effect of incorporated 137Cs on the mechanism of adrenergic control of myocardial contraction].
    Lobanok LM; Bulanova KIa; Gerasimovich NV; Sineleva MV; Miliutin AA
    Radiats Biol Radioecol; 1994; 34(4-5):651-6. PubMed ID: 7951898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of androgen treatment on adenylate cyclase system in rat hepatic membranes.
    Shima S
    Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):429-33. PubMed ID: 1332015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitro.
    Freissmuth M; Tuisl E; Steurer G; Schütz W
    Eur J Pharmacol; 1984 Sep; 104(1-2):169-72. PubMed ID: 6094208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Forskolin-stimulated adenylate cyclase activity in fetal and adult rabbit myocardial membranes.
    Hatjis CG
    Am J Obstet Gynecol; 1986 Dec; 155(6):1326-31. PubMed ID: 3024489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart.
    Tanaka H; Shigenobu K
    Br J Pharmacol; 1990 May; 100(1):138-42. PubMed ID: 2164856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low responsiveness of cardiac adenylate cyclase activity to peptide hormones in spontaneously hypertensive rats.
    Chatelain P; Robberecht P; de Neef P; Claeys M; Christophe J
    FEBS Lett; 1979 Nov; 107(1):86-90. PubMed ID: 499563
    [No Abstract]   [Full Text] [Related]  

  • 52. Stimulation of human cardiac adenylate cyclase by vanadate.
    Krawietz W; Werdan K; Erdmann E
    Basic Res Cardiol; 1980; 75(3):433-7. PubMed ID: 6905765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of beta-adrenergic receptor blockade or refractoriness induced by isoproterenol on growth of keratinocytes in vitro.
    Orenberg EK; Wilkinson DI
    Br J Dermatol; 1982 Nov; 107 Suppl 23():119-24. PubMed ID: 6291567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catecholamine-responsive adenylate cyclase activity in human endomyocardial biopsies. Individual sensitivity to isoproterenol stimulation and propranolol inhibition.
    Golf S; Jahnsen T; Simonsen S; Attramadal A; Hansson V
    Scand J Clin Lab Invest; 1985 Feb; 45(1):61-6. PubMed ID: 2858121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure.
    Bian XP; Seidler FJ; Slotkin TA
    J Dev Physiol; 1991 Dec; 16(6):331-9. PubMed ID: 1668597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of adrenergic stimulation on adenylate cyclase activity in rat prostate.
    Shima S; Kawashima Y; Hirai M; Asakura M
    Biochim Biophys Acta; 1980 Mar; 628(3):255-62. PubMed ID: 7370295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal changes in adenylate cyclase activity in acutely ischemic dog heart: evidence of functional subunit damage.
    Drummond RW; Sordahl LA
    J Mol Cell Cardiol; 1981 Mar; 13(3):323-30. PubMed ID: 6267301
    [No Abstract]   [Full Text] [Related]  

  • 58. Regulation of cardiac adenylate cyclase activity in rodent models of obesity.
    Strassheim D; Houslay MD; Milligan G
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):203-8. PubMed ID: 1348926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of phospholipids in hormone activation of adenylate cyclase.
    Levey GS
    Recent Prog Horm Res; 1973; 29():361-86. PubMed ID: 4356275
    [No Abstract]   [Full Text] [Related]  

  • 60. Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats.
    Robberecht P; Gillet L; Chatelain P; De Neef P; Camus JC; Vincent M; Sassard J; Christophe J
    Peptides; 1984; 5(2):355-8. PubMed ID: 6473161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.